Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model

Cancer Letters

Volumn 244, Issue 2, 2006, Pages 252-259

  Saha, Prosenjit ^a   Mandal, Suvra ^b   Das, Ashes ^b   Das, Sukta ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b Central Research Institute Ayurveda   (India)

Author keywords

Amarogentin; Apoptosis; Caspase 3; Chemoprevention; Cox II; Swertia

Indexed keywords

AMAROGENTIN; CASPASE 3; CYCLOOXYGENASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AYURVEDA; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; SWERTIA; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLUCOSIDES; IN SITU NICK-END LABELING; IRIDOIDS; MALE; MEDICINE, TRADITIONAL; MEMBRANE PROTEINS; MICE; PHYTOTHERAPY; PLANT EXTRACTS; SKIN NEOPLASMS; SWERTIA; UP-REGULATION;

SWERTIA; SWERTIA CHIRAYTA;

EID: 33749249917     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.12.036     Document Type: Article

References (41)

1. Drewnowski A., and Gomez-Carneros C. Bitter taste, phytonutrients, and consumer: a review. Am. J. Clin. Nutr. 72 (2000) 1424-1435
2. McBurney D.H. In: Carterette E.C., and Friedman M.P. (Eds). Psychological Dimensions and Perceptual Analysis of Taste. Handbook of Perception: Tasting and Smelling vol. 6A (1978), Academic Press, New York
3. Swami Sada Shiva Tirtha, Ayurvedic Encyclopedia, Ayurveda Holistic Center, 1997, pp. 29-31.
4. Friedhelmm K. Characteristic plant constituents. IX. Amarogentin, a new bitter principle from gentianaceae. Chem. Ber. 88 (1955) 704-707
5. Saha P., Mandal S., Das A., and Das S. Evaluation of the anticarcinogenic activity of swertia chirata buch.ham, an Indian medicinal plant, on DMBA induced mouse skin carcinogenesis model. Phytother. Res. 18 (2004) 373-378
6. Smith W., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and 2. J. Biol. Chem. 271 (1996) 33157-33160
7. Ledinghen V., Liu H., Zhang F., Lo C.R., Subbarmaiah K., Dannenberg A.J., et al. Induction of cyclooxygenase-2 by tumour promoters in transformed P4502E1-expressing hepatocytes. Carcinogenesis 23 (2002) 73-79
8. Singh J., Hamid R., and Reddy B.S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the post initiation stage of colon carcinogenesis. Cancer Res. 57 (1997) 3465-3470
9. Thornberry N.A. The caspase family of cystein protease. Br. Med. Bull. 53 (1997) 478-490
10. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290
11. Han Z., Hendricson E.A., Bremner T.A., and Wyche J.H. A sequential two step mechanism for the production of the mature p17:p12 from caspase-3 in vitro. J. Biol. Chem. 272 (1997) 13432-13436
12. Bedi A., Pasricha P.J., Akhtar A.J., Barber J.P., Bedi G.C., Giardiello F.M., et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res. 55 (1995) 1811-1816
13. Griffith J., and Aldrich T.E. In: Cooke C. (Ed). Epidemiologic Research Methods in Environmental Epidemiology and Risk Assessment (1993), Van Nostrand Reinhold, New York 27-60
14. Slaga T.J. Mechanisms involved in two-stage carcinogenesis in mouse skin,. In: Slaga T.J. (Ed). Mechanisms of Tumor Promotion (1984), CRC Press, Boca Raton, FL 1-93
15. Lowry O.H., Rosebrough N.J., Farr A., and Randall R.J. Protein measurement with folin phenol regent. J. Biol. Chem. 193 (1951) 265-275
16. 4. Nature (London) 227 (1970) 680-685
17. Chatterjee A., and Pakrashi S.C. The Treatise on Indian Medicinal Plants vol. 4 (1995), Public Information Directorate, CSIR, New Delhi pp. 92-94
18. Karan M., Vasisht K., and Handa S.S. Antihepatotoxic activity of swertia chirata on paracetamol and galactosamine induced hepatotoxicity in rats. Phytother. Res. 13 (1999) 95-101
19. Karan M., Vasisht K., and Handa S.S. Antihepatotoxic activity of swertia chirata on carbon tetrachloride induced hepatotoxicity in rats. Phytother. Res. 13 (1999) 24-30
20. Khanom F., Kayahara H., and Tadasa K. Superoxide scavenging and prolyl endopeptidase inhibitory activities of Bangladeshi indigenous medicinal plants. Biosci. Biotechnol. Biochem. 64 (2000) 837-884
21. Rafatullah S., Tariq M., Mossa J.S., al-Yhya M.S., and Ageel A.M. Protective effect of swertia chirata against indomethacin and other ulcerogenic agent induced gastric ulcers. Drugs Exp. Clin. Res. 19 (1993) 69-73
22. Ray S., Majumder H.K., Chakravarty A.K., Mukhopadhyay S., Gil R.R., and Cordell G.A. Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from leishmania donovani. J. Nat. Prod. 59 (1996) 27-29
23. Medda S., Mukhopadhyay S., and Basu M.K. Evaluation of the in vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms. J. Antimicrob. Chemother. 44 (1999) 791-794
24. Ivmlr S.K., Yadav A.K., Saxena A., and Paul B. Modulation of interleukin-1β, interleukin-4, interleukin-6, interleukin-10, tumor necrosis factor -α and interferon-γ by aqueous extract of Swertia chirata. Indian J. Pharmacol. 34 (2002) 141-155
25. Saha P., and Das S. Regulation of hazardous exposure by protective exposure-modulation of phase II detoxification and lipid peroxidation by camellia sinensis and swertia chirata. Teratog. Carcinog. Mutagen. 1 (2003) 313-322
26. Potten C.S. In: McGee J.O.D. (Ed). Cell Linages vol. 1 (1992), Oxford University Press, Oxford 43-52
27. Wyllie A.H., Kerr F.R., and Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68 (1980) 251-270
28. Ellis R.E., Yuan J., and Horvitz H.R. Mechanism and functions of cell death. Annu. Rev. Cell Biol. 7 (1991) 663-698
29. White E. Life death and pursuit of apoptosis. Genes Dev. 10 (1996) 1-5
30. Kerr J., Winterford C.M., and Harmon B.V. Apoptosis-its significance in cancer and cancer therapy. Cancer 73 (1994) 13-26
31. Barry M.A., Behnke C.A., and Estamann A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40 (1990) 2353-2362
32. Hickman J.A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11 (1992) 121-129
33. Sen S., and D'Incalci M. Biochemecal events and relevance to cancer chemotherapy. Fed. Eur. Biochem. Soc. Lett. 307 (1992) 122-127
34. Sculte-Hermann R., Kraupp Grasle B., and Bursch W. Dose response and threshold effects in cytotoxicity and apoptosis. Mutat. Res. 464 (2000) 13-18
35. Bursch W., Oberhammer F., and Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13 (1992) 245-251
36. Taraphadar A.K., Roy M., and Bhattacharya R.K. Natural product as inducers of apoptosis: implication of cancer therapy and prevention. Curr. Sci. 80 (2001) 4653-4659
37. Maldve R., and Fischer S.M. Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol. Carcinog. 7 (1996) 207-216
38. Steinbach G., Lynch P.M., Phillips K.S., Wallace M.H., Hawk E., Gordon G.B., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyoposis. N. Engl J. Med. 342 (2000) 1946-1952
39. Chowdhury N.I., Bandyopadhya S.K., Banerjee S.N., Dutta M.K., and Das P.C. Preliminary studies on the anti-inflammatory activity of swertia chirata in albino rats. Ind J. Pharmacol. 27 (1995) 37-39
40. Reed J.C. In: Alison M. (Ed). Apoptosis in the Cancer Handbook (2002), Nature Publication Group, London 119
41. Butler L.M., Hewett P.J., Fitridge R.A., and Cowled P.A. Deregulation of apoptosis in colorectal carcinoma: theoretical and therapeutic implications. ANZ J. Surg. 69 (1999) 88-94